Mikron (RXO) AGM 2025 presentation summary

Financial performance and key figures

• Net sales reached CHF 374.1 million in 2024, up 1% from the previous year, with an operating profit margin of 8.5% and free cash flow of CHF 48.9 million.

• Operating profit margin target remains at 7-10%, with a sustainable high single-digit margin achieved.

• Strong cash position and debt-free status, with expansion CAPEX of CHF 12.5 million in 2024.

• Proposed dividend of CHF 0.50 per share for 2024, maintaining the payout target of one-third of normalized net profit.

Business segments and market development

• Automation segment saw strong growth in Europe and Asia, especially in Pharma and MedTech, with a robust order backlog and workforce expansion in Switzerland.

• Machining segment secured long-term projects in watch, e-mobility, and writing industries, and entered the medical market.

• Tool segment experienced high demand, expanded applications in Pharma, MedTech, SemiCon, and Aviation, and strengthened consulting expertise.

• Digitalization initiatives include machine data connectivity, predictive maintenance, and energy management solutions.

Sustainability and ESG initiatives

• ESG targets integrated into 100% of top management objectives, with >97% employee training participation.

• Scope 1 and 2 emissions targeted to be reduced below 1,600 tCO₂eq, and 80% of main suppliers to sign the Supplier Code of Conduct.

• Social goals include achieving 15% women in the company, reducing employee turnover to 8.9%, and absenteeism rate below 3%.